OneChain’s CAR-T therapy OC-1 shows encouraging interim results in aggressive blood cancer

by OneChain Immunotherapeutics

New preliminary data presented at EHA 2026 highlight the potential of OC-1 in a rare and aggressive blood cancer with limited treatment options.

Read more

Curapath highlights its collaboration with Macro Biologics and celebrates the advancement of Amicidin α Surgical Gel toward Phase 1

by Curapath

Curapath is pleased to acknowledge the significant progress achieved by Macro Biologics, Inc., whose IND application for Amicidin‑α Surgical Gel has been accepted by the FDA, enabling the initiatio...

Read more

El Biobanco coordina la tramitación de muestras del ensayo fase 2 que utiliza oncovirus para revertir el mal pronóstico de pacientes con tumores cerebrales infantiles

by Cima Universidad de Navarra

El Biobanco Universidad de Navarra coordina la tramitación de muestras que se recogen en el ensayo clínico para pacientes con tumores cerebrales infantiles iniciado recientemente. Este estudio fase ...

Read more

Rethinking Alzheimer’s clinical trials to include atypical forms of the disease

by Fundació Clínic per a la Recerca Biomèdica

A paper published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association examines the limitations of current clinical trials in Alzheimer’s disease and proposes ways to better ada...

Read more

InnoUp Farma, backed by Sodena, Successfully Completes Phase 1 Trial of INP20, Its Innovative Oral Immunotherapy for Peanut Allergy

by Sodena

Unlike other therapies currently available or under development, INP20 is not designed to desensitise patients to the allergen. Instead, it aims to replicate the biological signals generated by the gu...

Read more

Los entornos estimulantes podrían acelerar la recuperación tras un ictus

by Universitat Rovira i Virgili

Un ensayo clínico con participación de la URV evalúa si incorporar actividades sociales, lúdicas y musicales a la rehabilitación mejora la recuperación funcional, cognitiva y emocional de los pa...

Read more

A therapeutic virus combined with immunotherapy shows promising results in advanced head and neck cancer

by ICO - Institut Català d'Oncologia

A Phase I clinical trial shows that the oncolytic virus VCN-01 can transform the tumor microenvironment and enhance the effect of immunotherapy in patients with poor prognosis.

Read more

Building Trust Through Quality-Driven Clinical Solutions

by Pivotal

As the clinical research industry continues to grow, companies are facing increasing pressure to meet strict regulatory requirements while keeping studies moving efficiently. Sponsors today need depen...

Read more

Fecundis HyperSperm technology increases the number and quality of embryos produced through in vitro fertilisation

by Parc Científic de Barcelona

It has been revealed that the use of HyperSperm technology, developed by this Barcelona-based company, increases not only the number of viable embryos but also their quality.

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream